Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Hammad, Ruba"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hammad, Ruba1,2,3,4 (AUTHOR) ruba.hammad@uniklinik-freiburg.de, Alzubi, Jamal1,2 (AUTHOR) jamal.alzubi@uniklinik-freiburg.de, Rhiel, Manuel1,2 (AUTHOR) manuel.rhiel@uniklinik-freiburg.de, Chmielewski, Kay O.1,2,4 (AUTHOR) kay.chmielewski@uniklinik-freiburg.de, Mosti, Laura1,2 (AUTHOR) mosti.laura@gmail.com, Rositzka, Julia1,2 (AUTHOR) julia.rositzka@uniklinik-freiburg.de, Heugel, Marcel1,2 (AUTHOR) marcel.heugel@live.de, Lawrenz, Jan1,2 (AUTHOR) vale.pennucci@gmail.com, Pennucci, Valentina1,2 (AUTHOR) tatjana.cornu@uniklinik-freiburg.de, Gläser, Birgitta5 (AUTHOR) birgitta.glaeser@uniklinik-freiburg.de, Fischer, Judith5,6 (AUTHOR) judith.fischer@uniklinik-freiburg.de, Schambach, Axel7,8 (AUTHOR) lachmann.nico@mh-hannover.de, Moritz, Thomas7,8 (AUTHOR) moritz.thomas@mh-hannover.de, Lachmann, Nico8,9,10,11,12 (AUTHOR), Cornu, Tatjana I.1,2,6 (AUTHOR) claudio.mussolino@uniklinik-freiburg.de, Mussolino, Claudio1,2,6 (AUTHOR) richard.schaefer@uniklinik-freiburg.de, Schäfer, Richard1,2,3,6 (AUTHOR), Cathomen, Toni1,2,6 (AUTHOR) toni.cathomen@uniklinik-freiburg.de
Publikováno v:
International Journal of Molecular Sciences. Jan2024, Vol. 25 Issue 2, p985. 15p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Wehbe, Zoé, Hammad, Ruba, Cathomen, Toni, Bohler, Sheila, Rajak, Jovana, Erlacher, Miriam, Ghanjati, Foued, Niemeyer, Charlotte, Flotho, Christian
Publikováno v:
In EJC Paediatric Oncology December 2023 2 Supplement 1
Autor:
Craig-Mueller, Nils, Hammad, Ruba, Elling, Roland, Alzubi, Jamal, Timm, Barbara, Kolter, Julia, Knelangen, Nele, Bednarski, Christien, Gläser, Birgitta, Ammann, Sandra, Ivics, Zoltán, Fischer, Judith, Speckmann, Carsten, Schwarz, Klaus, Lachmann, Nico, Ehl, Stephan, Moritz, Thomas, Henneke, Philipp, Cathomen, Toni
Publikováno v:
Frontiers in immunology, 11:608802
Frontiers in Immunology
Frontiers in Immunology
Inherited defects in MyD88 and IRAK4, two regulators in Toll-like receptor (TLR) signaling, are clinically highly relevant, but still incompletely understood. MyD88- and IRAK4-deficient patients are exceedingly susceptible to a narrow spectrum of pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::5414cbc18e63beaec04344659be227ea
https://www.frontiersin.org/articles/10.3389/fimmu.2020.608802/full#h11
https://www.frontiersin.org/articles/10.3389/fimmu.2020.608802/full#h11
Autor:
Craig-Mueller N; Institute for Transfusion Medicine and Gene Therapy, Medical Center-University of Freiburg, Freiburg, Germany.; Center for Chronic Immunodeficiency (CCI), Medical Center-University of Freiburg, Freiburg, Germany.; MD Program, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Hammad R; Institute for Transfusion Medicine and Gene Therapy, Medical Center-University of Freiburg, Freiburg, Germany.; Center for Chronic Immunodeficiency (CCI), Medical Center-University of Freiburg, Freiburg, Germany.; PhD Program, Faculty of Biology, University of Freiburg, Freiburg, Germany., Elling R; Center for Chronic Immunodeficiency (CCI), Medical Center-University of Freiburg, Freiburg, Germany.; Institute for Immunodeficiency, Medical Center-University of Freiburg, Freiburg, Germany.; Center for Pediatrics and Adolescent Medicine, Medical Center-University of Freiburg, Freiburg, Germany., Alzubi J; Institute for Transfusion Medicine and Gene Therapy, Medical Center-University of Freiburg, Freiburg, Germany.; Center for Chronic Immunodeficiency (CCI), Medical Center-University of Freiburg, Freiburg, Germany., Timm B; Institute for Transfusion Medicine and Gene Therapy, Medical Center-University of Freiburg, Freiburg, Germany.; Center for Chronic Immunodeficiency (CCI), Medical Center-University of Freiburg, Freiburg, Germany., Kolter J; Center for Chronic Immunodeficiency (CCI), Medical Center-University of Freiburg, Freiburg, Germany.; Institute for Immunodeficiency, Medical Center-University of Freiburg, Freiburg, Germany., Knelangen N; Center for Chronic Immunodeficiency (CCI), Medical Center-University of Freiburg, Freiburg, Germany.; Institute for Immunodeficiency, Medical Center-University of Freiburg, Freiburg, Germany., Bednarski C; Institute for Transfusion Medicine and Gene Therapy, Medical Center-University of Freiburg, Freiburg, Germany.; Center for Chronic Immunodeficiency (CCI), Medical Center-University of Freiburg, Freiburg, Germany., Gläser B; Institute of Human Genetics, Medical Center-University of Freiburg, Freiburg, Germany., Ammann S; Center for Chronic Immunodeficiency (CCI), Medical Center-University of Freiburg, Freiburg, Germany.; Institute for Immunodeficiency, Medical Center-University of Freiburg, Freiburg, Germany., Ivics Z; Division of Medical Biotechnology, Paul-Ehrlich Institute, Langen, Germany., Fischer J; Institute of Human Genetics, Medical Center-University of Freiburg, Freiburg, Germany.; Faculty of Medicine, University of Freiburg, Freiburg, Germany., Speckmann C; Center for Chronic Immunodeficiency (CCI), Medical Center-University of Freiburg, Freiburg, Germany.; Center for Pediatrics and Adolescent Medicine, Medical Center-University of Freiburg, Freiburg, Germany.; Faculty of Medicine, University of Freiburg, Freiburg, Germany., Schwarz K; Institute for Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Service Baden-Württemberg-Hessen, and Institute for Transfusion Medicine, University of Ulm, Ulm, Germany., Lachmann N; Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany.; REBIRTH Cluster for Regenerative and Translational Medicine, Hannover, Germany., Ehl S; Center for Chronic Immunodeficiency (CCI), Medical Center-University of Freiburg, Freiburg, Germany.; Institute for Immunodeficiency, Medical Center-University of Freiburg, Freiburg, Germany.; Faculty of Medicine, University of Freiburg, Freiburg, Germany., Moritz T; Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany.; REBIRTH Cluster for Regenerative and Translational Medicine, Hannover, Germany., Henneke P; Center for Chronic Immunodeficiency (CCI), Medical Center-University of Freiburg, Freiburg, Germany.; Institute for Immunodeficiency, Medical Center-University of Freiburg, Freiburg, Germany.; Center for Pediatrics and Adolescent Medicine, Medical Center-University of Freiburg, Freiburg, Germany.; Faculty of Medicine, University of Freiburg, Freiburg, Germany., Cathomen T; Institute for Transfusion Medicine and Gene Therapy, Medical Center-University of Freiburg, Freiburg, Germany.; Center for Chronic Immunodeficiency (CCI), Medical Center-University of Freiburg, Freiburg, Germany.; Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Publikováno v:
Frontiers in immunology [Front Immunol] 2020 Dec 23; Vol. 11, pp. 608802. Date of Electronic Publication: 2020 Dec 23 (Print Publication: 2020).